M-A: Long-acting injectable vs. oral antipsychotics for the maintenance treatment of schizophrenia
15 Apr, 2021 | 06:31h | UTC
Commentary on Twitter
"Taken together, the results suggest increased use of long-acting injectable antipsychotics in clinical practice should be considered."
New Researchhttps://t.co/l2Ow9BzCUu
— The Lancet Psychiatry (@TheLancetPsych) April 14, 2021